# Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer

> **NCT00017407** · PHASE3 · COMPLETED · sponsor: **Ionis Pharmaceuticals, Inc.**

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** ISIS 3521
- **DRUG:** carboplatin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00017407
- **Lead sponsor:** Ionis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10-13
- **Primary completion:** 2002-09-09
- **Final completion:** 2002-09-09
- **Target enrollment:** — (—)
- **Last updated:** 2022-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017407, "Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00017407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*